Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center

FDA Approves Eprontia

FDA Approves Eprontia (topiramate) Oral Solution for Epilepsy and Preventive Treatment of Migraine WOBURN, MA, November 8, 2021 – Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet

Clinical Care May Impact Gray Matter Volume in Migraine Patients

TUESDAY, Nov. 9, 2021 -- Patients with migraine without prior clinical care have reduced gray matter volume (GMV) in the right dorsal medial prefrontal cortex (dMPFC) compared to those with prior care, according to a study published online Oct. 23 in The

One-Third Have Symptoms Two Months After SARS-CoV-2

One-Third Have Symptoms Two Months After SARS-CoV-2 TUESDAY, Sept. 21, 2021 -- One-third of individuals report having at least one symptom two months after having a positive test result for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), ac

Infant Deaths Spark Baby Loungers Recall

Infant Deaths Spark Baby Loungers Recall FRIDAY, Sept. 24, 2021 -- The death of eight babies has prompted the Boppy Company and the U.S. Consumer Product Safety Commission (CPSC) to recall more than 3 million baby loungers, they announced Thursday. Wh